Altering The Immune System to Reverse Paralysis: Mouse Study

Summary: An experimental treatment can generate immune cells that migrate to the brain and prevent attacks against myelin, allowing mice the ability to regain walking skills.

Source: American Chemical Society.

In the ultimate betrayal, one’s own immune system can turn against the protective sheath that envelops neurons in the brain, leaving the body paralyzed. Researchers have developed an experimental treatment that tames the wayward immune system in rodents, returning the power of movement to paralyzed mice. The approach may someday combat autoimmune diseases, such as multiple sclerosis and type 1 diabetes, in humans.

The researchers will present their work today at the 253rd National Meeting & Exposition of the American Chemical Society (ACS). ACS, the world’s largest scientific society, is holding the meeting here through Thursday. It features more than 14,000 presentations on a wide range of science topics.

“The problem with current immunotherapies is that they aren’t specific,” says Christopher Jewell, Ph.D. “They act broadly, compromising the entire immune system and putting the patient’s health at risk, rather than focusing on only those immune system cells doing the damage.”

By considering how the immune system works, Jewell’s team at the University of Maryland set their sights on the lymph nodes as a possible target for creating a specific immune response. In autoimmune disease, a body-roaming immune cell recognizes an antigen — a molecule that the cell in this case falsely identifies as a piece of a foreign invader — and brings it to the lymph nodes, where another type of immune cell, the T cell, is then programmed to attack the antigen. For example, in multiple sclerosis, T cells are taught to recognize and attack the myelin sheath. Jewell thought it might be possible to prevent the T cells from learning bad habits by delivering an immune-system modifying agent directly to the lymph nodes.

Image shows a cartoon of T cells.

To build the immunotherapeutic agent, the researchers first constructed a particle from poly(lactide-co-glycolide), an FDA-approved polymer, to serve as a carrier. They infused it with an immune-suppressing agent and the myelin antigen, to teach the T cells that myelin is no enemy. NeuroscienceNews.com image is adapted from the American Chemical Society video.

To build the immunotherapeutic agent, the researchers first constructed a particle from poly(lactide-co-glycolide), an FDA-approved polymer, to serve as a carrier. They infused it with an immune-suppressing agent and the myelin antigen, to teach the T cells that myelin is no enemy.

The researchers injected these particles into the lymph nodes of paralyzed mice exhibiting a mouse model of multiple sclerosis. The particles slowly reprogrammed the environment of the lymph node tissues to generate immune cells that migrated to the brain to stop the attack against myelin. These mice regained the ability to walk, and the effects lasted for the duration of the study, which was about 80 days. The mice were also able to readily respond when foreign molecules were introduced, suggesting that the treatment didn’t compromise normal immune function.

As a next step, the researchers have been testing the idea in other mouse models of autoimmune disease, including transplant models and models of type 1 diabetes — a disease in which the immune system attacks the pancreas. Later this year, the group will team up with clinicians at the University of Maryland Medical School to begin tests in non-human primates, another step closer to investigating this idea as a future human therapy.

About this neurology research article

Jewell acknowledges funding for this project from the National Multiple Sclerosis Society, the U.S. Department of Veterans Affairs and the National Science Foundation.

Source: American Chemical Society
Image Source: NeuroscienceNews.com image is adapted from the American Chemical Society video.
Video Source: The video is credited to American Chemical Society.
Original Research: The study will be presented at the American Chemical Society 253rd National Meeting & Exposition in San Francisco between April 2 – 6, 2017.

Cite This NeuroscienceNews.com Article
American Chemical Society “Altering The Immune System to Reverse Paralysis: Mouse Study.” NeuroscienceNews. NeuroscienceNews, 3 April 2017.
<http://neurosciencenews.com/paralysis-immune-system-6329/>.
American Chemical Society (2017, April 3). Altering The Immune System to Reverse Paralysis: Mouse Study. NeuroscienceNew. Retrieved April 3, 2017 from http://neurosciencenews.com/paralysis-immune-system-6329/
American Chemical Society “Altering The Immune System to Reverse Paralysis: Mouse Study.” http://neurosciencenews.com/paralysis-immune-system-6329/ (accessed April 3, 2017).
Feel free to share this Neuroscience News.
Join our Newsletter
I agree to have my personal information transferred to AWeber for Neuroscience Newsletter ( more information )
Sign up to receive the latest neuroscience headlines and summaries sent to your email daily from NeuroscienceNews.com
We hate spam and only use your email to contact you about newsletters. We do not sell email addresses. You can cancel your subscription any time.
No more articles